Atlas Trials

Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout

Clinical trial NCT00985127 · COMPLETED

Trial details

NCT number
NCT00985127
Sponsor
BioCryst Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gout
Start date
2009-09-01
Primary completion
2010-09-01
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.